Citation
Select
McKeith I, Del Ser T, Spano P, Emre M, Wesnes K, Anand R, Cicin-Sain A, Ferrara R, Spiegel R
Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study
Lancet. 2000 Dec 16;356(9247):2031-6
Citation
Select
Heathcote EJ, Shiffman ML, Cooksley WG, Dusheiko GM, Lee SS, Balart L, Reindollar R, Reddy RK, Wright TL, Lin A, Hoffman J, De Pamphilis J
Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis
N Engl J Med. 2000 Dec 7;343(23):1673-80
Citation
Select
Zeuzem S, Feinman SV, Rasenack J, Heathcote EJ, Lai MY, Gane E, O'Grady J, Reichen J, Diago M, Lin A, Hoffman J, Brunda MJ
Peginterferon alfa-2a in patients with chronic hepatitis C
N Engl J Med. 2000 Dec 7;343(23):1666-72
Citation
Select
The Lung Health Study Research Group.
Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease.
N Engl J Med. 2000 Dec 28;343(26):1902-1909
Citation
Select
Blood Pressure Lowering Treatment Trialists' Collaboration
Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials
Lancet. 2000 Dec 9;356(9246):1955-64
Citation
Select
Marco Pahor, Bruce M Psaty, Michael H Alderman, William B Applegate, Jeff D Williamson, Chiara Cavazzini, Curt D Furberg
Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials
Lancet. 2000 Dec 9;356(9246):1949-54